Retrobulbar optic neuritis associated with infliximab;Neuritis óptica desmielinizante tras tratamiento con infliximab

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 82, Issue 2, 2007, Pages 109-112

  Bidaguren Urbieta, Aritz ^a,b   Muller Thyssen A ^a   Blanco, A ^a   Mendicute, J ^a   Ubeda M ^a  

^a HOSPITAL DONOSTIA   (Spain)

^b NONE   (Spain)

Author keywords

Demyelination; Infliximab; Multiple sclerosis; Optic neuritis; TNFa inhibitors

Indexed keywords

ANTIRHEUMATIC AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; OPTIC NEURITIS;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; OPTIC NEURITIS;

EID: 34347206399     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Foroozan R, Buono LM, Sergott RC, Savino PJ. Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol 2002; 120: 985-987.
2. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsman FW, et al. Increased MRI activity and inmune reaction in two multiple esclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996; 47: 1531-1534.
3. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: Results of a randomized, placebo-controled multicenter study. Neurology 1995; 53: 457-465.
4. Strong BY, Enry BC, Herzenberg H, Razzeca KJ. Retrobulbar optic neuritis associated with Infliximab in a patient with Crohn Disease. Ann Intern Med 2004; 20: 140: E678.
5. Rebolleda G. Infliximab y neuritis óptica. Arch Soc Esp Oftalmol 2004; 79: 591.